About Zenotech Laboratories Ltd
Zenotech Laboratories is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anaesthesiology.
Founded
1989
CEO
N/A
Employees
228
HQ
Hyderabad, Telangana
Finished Products
1Revenue from operations
₹75.74Cr2Other Operating Revenue
₹8.14CrRaw Materials
1Cost of material Consumed
₹0.84CrAbout Zenotech Laboratories Ltd
Zenotech Laboratories is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anaesthesiology.
Founded:1989
CEO:N/A
Employees:228
HQ:Hyderabad, Telangana
Finished Products
1Revenue from operations
₹75.74Cr2Other Operating Revenue
₹8.14CrRaw Materials
1Cost of material Consumed
₹0.84CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹58
52W Low
₹34
Volume15.04K
Avg VolumeN/A
Beta1.18
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-113.17x
Valuation
P/B Ratio
2.98x
Valuation
EPS
₹-0.41
Valuation
Dividend Yield
0.00%
Valuation
ROE
-1.13%
Profitability
ROCE
4.36%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-7.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.